Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

ASNI Calgary 2015
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Microglia in health and disease.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Episode 33 with Dr. Pierre-Antoine Gourraud on the role of human leukocyte antigen in MS
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
The use of hematopoietic stem cells in autoimmune diseases.
JC polyomavirus mutants escape antibody-mediated neutralization.
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.

Pages